Can I Get a Piece of This?

This story showed up in my newsfeed last week. Its relevance? The company for which pharmaceutical giant Eli Lilly is paying $8 billion dollars is Kelonia Theraputics. Those of you paying close attention will remember that Kelonia is the developer of the new multiple myeloma treatment KLN-1010, which (if all goes well) I’ll be getting the week after next as part of a Phase 1 trial at Stanford. I took […]






